NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $56,000 | -16.4% | 801 | -0.2% | 0.02% | +14.3% |
| Q1 2022 | $67,000 | +11.7% | 803 | 0.0% | 0.01% | +16.7% |
| Q4 2021 | $60,000 | -35.5% | 803 | 0.0% | 0.01% | -42.9% |
| Q3 2021 | $93,000 | -18.4% | 803 | 0.0% | 0.02% | -16.0% |
| Q2 2021 | $114,000 | -14.9% | 803 | -20.8% | 0.02% | -19.4% |
| Q1 2021 | $134,000 | -38.2% | 1,014 | -19.1% | 0.03% | -36.7% |
| Q4 2020 | $217,000 | -5.2% | 1,253 | -63.1% | 0.05% | -44.3% |
| Q1 2020 | $229,000 | +54.7% | 3,393 | +92.0% | 0.09% | +104.7% |
| Q4 2019 | $148,000 | – | 1,767 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |